Comment on "noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration"

被引：1
|
作者：
Wang, Liangcheng [1 ]
Horiuchi, Isao [1 ]
Takagi, Kenjiro [1 ]
机构：
[1] Jichi Med Univ, Saitama Med Ctr, Perinatal & Maternal Ctr, Saitama, Japan
来源：
PRENATAL DIAGNOSIS | 2019年 / 39卷 / 02期
关键词：
D O I：
10.1002/pd.5380
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 29 条
  • [21] Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
    Guibert, N.
    Hu, Y.
    Feeney, N.
    Kuang, Y.
    Plagnol, V.
    Jones, G.
    Howarth, K.
    Beeler, J. F.
    Paweletz, C. P.
    Oxnard, G. R.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 1049 - 1055
  • [22] Next-generation sequencing analysis of high-quality and high-quantity cell-free circulating DNA prepared from droplet volumes of patient plasma
    Yeh, Chen-Hsiung
    Spurgin, Jonathan
    Ford, Andrew
    Athanasuleas, John
    McLarty, Jennifer
    Mullen, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform
    Choudhury, Yukti
    Pinweha, Pannapa
    Poh, Jonathan
    Lim, Jing Shan
    Tan, Min-Han
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Use of the Quantitative Karius® Plasma Next Generation Sequencing Cell-Free Pathogen DNA Test to Detect and Monitor Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients
    Fung, Monica
    Teraoka, Justin
    Lien, Kathy
    Seng, Hon
    Parham, Adama
    Hollemon, Desiree
    Hong, David K.
    Blair, Lily
    Zompi, Simona
    Logan, Aaron C.
    Yao, Joseph D.
    Chin-Hong, Peter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies
    Stokowski, Renee
    Wang, Eric
    White, Karen
    Batey, Annette
    Jacobsson, Bo
    Brar, Herb
    Balanarasimha, Madhumitha
    Hollemon, Desiree
    Sparks, Andrew
    Nicolaides, Kypros
    Musci, Thomas J.
    PRENATAL DIAGNOSIS, 2015, 35 (12) : 1243 - 1246
  • [26] Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non-Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based Results
    Steendam, Christi M. J.
    Atmodimedjo, Peggy
    de Jonge, Evert
    Paats, Marthe S.
    van der Leest, Cor
    Oomen-de Hoop, Esther
    von der ThUsen, Jan H.
    Dinjens, Winand N. M.
    van Schaik, Ron H. N.
    Aerts, Joachim G. J., V
    Dubbink, Hendrikus Jan
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 9
  • [27] PIK3CA mutational analysis using cell-free DNA next-generation sequencing detects activating mutations that may be missed with targeted hot-spot testing
    Kiedrowski, Lesli A.
    Juric, Dejan
    Hardin, Aaron I.
    Price, Kristin S.
    Nagy, Rebecca J.
    Arteaga, Carlos L.
    O'Shaughnessy, Joyce
    Bardia, Aditya
    Cristofanilli, Massimo
    Lanman, Richard B.
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Real-world performance of a multi-cancer early detection test based on integrative analysis of cell-free DNA whole-methylome sequencing.
    Li, Yulong
    Song, Xiaofeng
    Shen, Ning
    Hong, Yuanyuan
    Yang, Ying
    Huang, Yu S.
    Chen, Weizhi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
    Koukourakis, Michael I.
    Xanthopoulou, Erasmia
    Koukourakis, Ioannis M.
    Fortis, Sotirios P.
    Kesesidis, Nikolaos
    Kakouratos, Christos
    Karakasiliotis, Ioannis
    Baxevanis, Constantin N.
    CURRENT ONCOLOGY, 2023, 30 (10) : 8902 - 8915
123